文献速递神经创伤神经重症

重型创伤性脑损伤高保真多模态监测的现状

Current state of high-fidelity multimodal monitoring in traumatic brain injury.
PubMed 文献 · Acta Neurochir (Wien) · 2022-10-19

本文综述重型创伤性脑损伤多模态监测的现状,涵盖有创监测(颅内压、脑灌注压、压力反应指数、脑组织氧分压、脑微透析)与无创监测(近红外光谱、经颅多普勒、血液生物标志物),指出多数指标阈值缺乏高级别证据,数据解读是核心,并强调成本效益与进一步研究的必要性。

要点

  • 颅内压是重型创伤性脑损伤有创监测的基石,应避免压力超过22 mmHg。
  • 脑组织氧分压的3期研究正在进行,以确定其在颅内压监测之外对结局的附加效应。
  • 有创监测总体安全,约10%病例报告医源性出血,但可能不影响长期结局。

核心结论

  • 多模态监测最重要的是数据解读,需了解每项指标的优点与局限。
  • 联合多种模式可能识别适合治疗的特定病理状态,但增加多项指标的增量获益证据级别低,需考虑成本效益,因此有必要进一步研究。

研究设计与样本

  • 本文为综述,围绕重型创伤性脑损伤的多模态监测,涵盖有创与无创技术及其指标、阈值与证据现状。

主要发现

  • 颅内压是重型创伤性脑损伤有创监测的基石,应避免压力超过22 mmHg。
  • 由颅内压可推导脑灌注压(平均动脉压减颅内压)和压力反应指数(平均动脉压与颅内压慢波之间的相关性,作为脑血管反应性的替代指标)。
  • 脑组织氧分压是常用的区域监测手段,3期研究正在进行以确定其在颅内压监测之外对结局的附加效应。
  • 脑微透析是另一种区域有创监测方式,用于测量脑细胞外液中的物质,国际联盟已提出阈值和管理策略,尽管缺乏高级别证据。
  • 有创监测总体安全,约10%病例报告医源性出血,但可能不显著影响长期结局。

关键数值与推荐

  • 2016年最新脑创伤基金会指南对部分指标和阈值给出了推荐和阈值,但多项指标和阈值缺乏高级别证据。
  • 颅内压应避免超过22 mmHg。
  • 国际联盟已提出脑微透析的阈值和管理策略,尽管缺乏高级别证据。
  • 有创监测中医源性出血报告率约10%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多项指标和阈值缺乏高级别证据。
  • 脑微透析的阈值和管理策略由国际联盟提出,但缺乏高级别证据。
  • 无创监测研究通常来自单中心回顾性经验。
  • 增加多项指标的增量获益证据级别低,因此有必要进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Multimodality monitoring of patients with severe traumatic brain injury (TBI) is primarily performed in neuro-critical care units to prevent secondary harmful brain insults and facilitate patient recovery. Several metrics are commonly monitored using both invasive and non-invasive techniques. The latest Brain Trauma Foundation guidelines from 2016 provide recommendations and thresholds for some of these. Still, high-level evidence for several metrics and thresholds is lacking. METHODS: Regarding invasive brain monitoring, intracranial pressure (ICP) forms the cornerstone, and pressures above 22 mmHg should be avoided. From ICP, cerebral perfusion pressure (CPP) (mean arterial pressure (MAP)-ICP) and pressure reactivity index (PRx) (a correlation between slow waves MAP and ICP as a surrogate for cerebrovascular reactivity) may be derived. In terms of regional monitoring, partial brain tissue oxygen pressure (PbtO2) is commonly used, and phase 3 studies are currently ongoing to determine its added effect to outcome together with ICP monitoring. Cerebral microdialysis (CMD) is another regional invasive modality to measure substances in the brain extracellular fluid. International consortiums have suggested thresholds and management strategies, in spite of lacking high-level evidence. Although invasive monitoring is generally safe, iatrogenic hemorrhages are reported in about 10% of cases, but these probably do not significantly affect long-term outcome. Non-invasive monitoring is relatively recent in the field of TBI care, and research is usually from single-center retrospective experiences. Near-infrared spectrometry (NIRS) measuring regional tissue saturation has been shown to be associated with outcome. Transcranial doppler (TCD) has several tentative utilities in TBI like measuring ICP and detecting vasospasm. Furthermore, serial sampling of biomarkers of brain injury in the blood can be used to detect secondary brain injury development. CONCLUSIONS: In multimodal monitoring, the most important aspect is data interpretation, which requires knowledge of each metric's strengths and limitations. Combinations of several modalities might make it possible to discern specific pathologic states suitable for treatment. However, the cost-benefit should be considered as the incremental benefit of adding several metrics has a low level of evidence, thus warranting additional research.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Lindblad C, Raj R, Zeiler FA, et al. Current state of high-fidelity multimodal monitoring in traumatic brain injury. Acta Neurochir (Wien). 2022. PMID: 36260235. doi:10.1007/s00701-022-05383-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。